News

Introduction: what are therapeutic oligonucleotides? The fight against cancer is entering a new era, fuelled by a wave of innovation in precision and personalized medicine. Therapeutic oligonucleotides are to highlight in this regard: short, synthetic strands of nucleic acids that can modulate gene expression with unparalleled specificity. As science deepens our understanding of cancer at […]

Last month, the TAONas-LUAD consortium reunited in Barcelona for its third Annual Meeting, an important milestone as the project enters its final year. The meeting, held on May 5–6, brought together partners from all participating institutions, alongside our advisory teams, for two days of exchange, reflection, and planning. The gathering provided a great opportunity for

On April 2–3, members of the TAONas-LUAD project team participated in the EIC Summit 2025, the flagship event of the European Innovation Council. Held in Brussels, the event brought together over 1,400 participants, including 115 speakers and 23 exhibitors, all showcasing the transformative potential of EIC-funded initiatives. Our project was represented by Alba Andrés, Project

The TAONas LUAD Project Hosts Its 2nd Annual Meeting in Barcelona  Barcelona, June 20th, 2024. The TAONas LUAD project, an innovative drug development effort funded by the European Union’s HORIZON 2020 EIC Transition program, held a productive and inspiring 2nd General Assembly.  They recapped the progress of the past year and made important decisions about

TAONas-LUAD: Marking a significant presence at the largest Biotech Event in Spain! BIOSPAIN is one of the largest biotech events in the world, organized by a national bioindustry association in Europe. This event gathers diverse groups of people from all around the world (a third from outside of Spain). Over 5,000 one to one meetings

On May 4th and 5th, 2022 we had the Kick-off Meeting of our project that is funded by an European Innovation Council (EIC) Transition Grant. The consortium members formed by CRG, SINTEF, Inveniam Group and INSERM met for the first time in person at the Centre for Genomic Regulation (CRG). The TAONas-LUAD project aims to